In this regard, it is important to consider that a CD16 downregulation was previously described also on PF-NK cells from ovarian cancer patients, mainly due to soluble factors, including IL-18 and TGF-beta (34, 35), present in this compartment. The gene discussed is IL18; the disease is ovarian carcinoma.